JOURNAL OF GASTROINTESTINAL ONCOLOGY, vol.2, no.1, pp.19-26, 2011 (SCI-Expanded)
Article / Article
JOURNAL OF GASTROINTESTINAL ONCOLOGY
Science Citation Index Expanded (SCI-EXPANDED), Emerging Sources Citation Index (ESCI), Scopus
Istanbul University Affiliated:
Background: Best response rates have been achieved with three-drug regimens containing 5-FU in the treatment of advanced gastric cancer (AGC) and oral fluoropyrimidines are the best alternatives as substitutes for infusional 5-FU. This study aimed to evaluate the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) regimens in AGC outpatients.